Home/Filings/4/0000899243-22-008581
4//SEC Filing

HOLMLUND JON T 4

Accession 0000899243-22-008581

CIK 0001563577other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:05 PM ET

Size

5.5 KB

Accession

0000899243-22-008581

Insider Transaction Report

Form 4
Period: 2022-02-28
HOLMLUND JON T
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-28+75,00075,000 total
    Exercise: $2.24Exp: 2032-02-27Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on March 28, 2022.

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001227367

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:05 PM ET
Size
5.5 KB